Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Microbiome Cosmetic Products Market

ID: MRFR/CG/11650-HCR
100 Pages
Garvit Vyas
Last Updated: April 06, 2026
US Microbiome Cosmetic Products Market Size, Share, Industry Trend & Analysis Research Report Information By Microbial component (Lactobacillus, Lactococcus, Streptococcus, Acetobacter, Leuconostoc, Bifidobacterium, Saccharomyces, Bacillus, Pediococcus, Zygosaccharomyces, Aspergillus, Micrococcus, and Others),Ingredient (Probiotic, Prebiotic, and Postbiotic), Format (Cream/Lotion, Serum, Cleanser/Face Wash, Spot Treatment, Masks, Skin Tonic/Toner, Face Oil, Scrubs, Sunscreen, Supplements, ), Claim, Consumer Group , Age, Distribution Channel-Forecast 2030
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Microbial Component (USD Million)
      1. 4.1.1 Lactobacillus
      2. 4.1.2 Lactococcus
      3. 4.1.3 Streptococcus
      4. 4.1.4 Acetobacter
      5. 4.1.5 Leuconostoc
      6. 4.1.6 Bifidobacterium
      7. 4.1.7 Saccharomyces
      8. 4.1.8 Bacillus
      9. 4.1.9 Pediococcus
      10. 4.1.10 Zygosaccharomyces
      11. 4.1.11 Aspergillus
      12. 4.1.12 Micrococcus
      13. 4.1.13 Others
    2. 4.2 Life Sciences, BY Ingredient (USD Million)
      1. 4.2.1 Probiotic
      2. 4.2.2 Prebiotic
      3. 4.2.3 Postbiotic
    3. 4.3 Life Sciences, BY Format (USD Million)
      1. 4.3.1 Cream/Lotion
      2. 4.3.2 Serum
      3. 4.3.3 Cleanser/Face Wash
      4. 4.3.4 Spot Treatment
      5. 4.3.5 Masks
      6. 4.3.6 Skin Tonic/Toner
      7. 4.3.7 Face Oil
      8. 4.3.8 Scrubs
      9. 4.3.9 Sunscreen
      10. 4.3.10 Supplements
      11. 4.3.11 Mist/Spray
      12. 4.3.12 Pads/Wipes
      13. 4.3.13 Gels
      14. 4.3.14 Others
    4. 4.4 Life Sciences, BY Claim (USD Million)
      1. 4.4.1 Acne
      2. 4.4.2 Hydration
      3. 4.4.3 Smooth/Brighten
      4. 4.4.4 Environmental Damage
      5. 4.4.5 Cellular Aging
      6. 4.4.6 Wound Healing
      7. 4.4.7 Atopic Dermatitis
      8. 4.4.8 Eczema
      9. 4.4.9 Rosacea
      10. 4.4.10 Psoriasis
      11. 4.4.11 Others
    5. 4.5 Life Sciences, BY Consumer Group (USD Million)
      1. 4.5.1 Women
      2. 4.5.2 Men
    6. 4.6 Life Sciences, BY Age (USD Million)
      1. 4.6.1 Babies (0-4)
      2. 4.6.2 Children (5-12)
      3. 4.6.3 Gen Z (13-24)
      4. 4.6.4 Millennials (25-40)
      5. 4.6.5 Gen X (41-56)
      6. 4.6.6 Baby Boomers (57-75)
      7. 4.6.7 Post-War Cohort (+75)
    7. 4.7 Life Sciences, BY Distribution Channel (USD Million)
      1. 4.7.1 Online Channels
      2. 4.7.2 Drug Stores & Pharmacies
      3. 4.7.3 Specialty Stores
      4. 4.7.4 Supermarkets & Hypermarkets
      5. 4.7.5 Department Stores
      6. 4.7.6 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Procter & Gamble (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 L'Oreal (FR)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Unilever (GB)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Estée Lauder (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Shiseido (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Beiersdorf (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Johnson & Johnson (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Coty (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY MICROBIAL COMPONENT
    3. 6.3 US MARKET ANALYSIS BY INGREDIENT
    4. 6.4 US MARKET ANALYSIS BY FORMAT
    5. 6.5 US MARKET ANALYSIS BY CLAIM
    6. 6.6 US MARKET ANALYSIS BY CONSUMER GROUP
    7. 6.7 US MARKET ANALYSIS BY AGE
    8. 6.8 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    9. 6.9 KEY BUYING CRITERIA OF LIFE SCIENCES
    10. 6.10 RESEARCH PROCESS OF MRFR
    11. 6.11 DRO ANALYSIS OF LIFE SCIENCES
    12. 6.12 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    13. 6.13 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    14. 6.14 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    15. 6.15 LIFE SCIENCES, BY MICROBIAL COMPONENT, 2024 (% SHARE)
    16. 6.16 LIFE SCIENCES, BY MICROBIAL COMPONENT, 2024 TO 2035 (USD Million)
    17. 6.17 LIFE SCIENCES, BY INGREDIENT, 2024 (% SHARE)
    18. 6.18 LIFE SCIENCES, BY INGREDIENT, 2024 TO 2035 (USD Million)
    19. 6.19 LIFE SCIENCES, BY FORMAT, 2024 (% SHARE)
    20. 6.20 LIFE SCIENCES, BY FORMAT, 2024 TO 2035 (USD Million)
    21. 6.21 LIFE SCIENCES, BY CLAIM, 2024 (% SHARE)
    22. 6.22 LIFE SCIENCES, BY CLAIM, 2024 TO 2035 (USD Million)
    23. 6.23 LIFE SCIENCES, BY CONSUMER GROUP, 2024 (% SHARE)
    24. 6.24 LIFE SCIENCES, BY CONSUMER GROUP, 2024 TO 2035 (USD Million)
    25. 6.25 LIFE SCIENCES, BY AGE, 2024 (% SHARE)
    26. 6.26 LIFE SCIENCES, BY AGE, 2024 TO 2035 (USD Million)
    27. 6.27 LIFE SCIENCES, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    28. 6.28 LIFE SCIENCES, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    29. 6.29 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY MICROBIAL COMPONENT, 2025-2035 (USD Million)
      2. 7.2.2 BY INGREDIENT, 2025-2035 (USD Million)
      3. 7.2.3 BY FORMAT, 2025-2035 (USD Million)
      4. 7.2.4 BY CLAIM, 2025-2035 (USD Million)
      5. 7.2.5 BY CONSUMER GROUP, 2025-2035 (USD Million)
      6. 7.2.6 BY AGE, 2025-2035 (USD Million)
      7. 7.2.7 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Life Sciences Market Segmentation

Life Sciences By Microbial Component (USD Million, 2025-2035)

  • Lactobacillus
  • Lactococcus
  • Streptococcus
  • Acetobacter
  • Leuconostoc
  • Bifidobacterium
  • Saccharomyces
  • Bacillus
  • Pediococcus
  • Zygosaccharomyces
  • Aspergillus
  • Micrococcus
  • Others

Life Sciences By Ingredient (USD Million, 2025-2035)

  • Probiotic
  • Prebiotic
  • Postbiotic

Life Sciences By Format (USD Million, 2025-2035)

  • Cream/Lotion
  • Serum
  • Cleanser/Face Wash
  • Spot Treatment
  • Masks
  • Skin Tonic/Toner
  • Face Oil
  • Scrubs
  • Sunscreen
  • Supplements
  • Mist/Spray
  • Pads/Wipes
  • Gels
  • Others

Life Sciences By Claim (USD Million, 2025-2035)

  • Acne
  • Hydration
  • Smooth/Brighten
  • Environmental Damage
  • Cellular Aging
  • Wound Healing
  • Atopic Dermatitis
  • Eczema
  • Rosacea
  • Psoriasis
  • Others

Life Sciences By Consumer Group (USD Million, 2025-2035)

  • Women
  • Men

Life Sciences By Age (USD Million, 2025-2035)

  • Babies (0-4)
  • Children (5-12)
  • Gen Z (13-24)
  • Millennials (25-40)
  • Gen X (41-56)
  • Baby Boomers (57-75)
  • Post-War Cohort (+75)

Life Sciences By Distribution Channel (USD Million, 2025-2035)

  • Online Channels
  • Drug Stores & Pharmacies
  • Specialty Stores
  • Supermarkets & Hypermarkets
  • Department Stores
  • Others